Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 8,786 shares at $2.83 ($25K) on 2016-06-20, disclosed to the SEC on 2016-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.71 | 550 | $1K | 6.0% |
| 2 | $2.83 | 1 | $3 | 0.0% |
| 3 | $2.84 | 5,431 | $15K | 61.7% |
| 4 | $2.87 | 1,019 | $3K | 11.7% |
| 5 | $2.88 | 85 | $245 | 1.0% |
| 6 | $2.89 | 1,700 |
| $5K |
| 19.7% |
| Total | $2.85 avg | 8,786 | $25K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |
| OHRP | BUY | 2016-03-09 | $23K | — | Filing → |